CINA CHEST vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA CHEST

by Avicenna.AI

AI-CVD

by HeartLung Corporation

AI Verdict

CINA CHEST is designed for rapid radiological triage and notification of acute, life-threatening conditions like Pulmonary Embolism and Aortic Dissection on CT angiography scans. In contrast, AI-CVD focuses on opportunistic screening for chronic cardiovascular and multisystem diseases, providing quantitative measurements from existing CT scans to identify hidden health risks. While both utilize AI on CT imaging for cardiovascular insights, their primary applications address different clinical urgencies and disease stages.

Choose CINA CHEST if…

Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for acute, life-threatening chest conditions like Pulmonary Embolism and Aortic Dissection in an emergency setting. This tool is designed to quickly flag suspected positive findings on CT angiography scans, assisting radiologists in prioritizing critical cases and optimizing emergency workflow.

View CINA CHEST →

Choose AI-CVD if…

Choose AI-CVD if your goal is opportunistic screening for cardiovascular and multisystem diseases by leveraging existing CT scans to identify hidden health risks. This platform excels at providing automated quantitative measurements, such as Coronary Artery Calcium scoring and cardiac chamber volumetry, without requiring additional imaging or disrupting current workflows, making it ideal for proactive disease detection and risk assessment.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA CHEST	AI-CVD
Pricing	Subscription-based	Contact for pricing
Deployment	Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)	Cloud
FDA Status	K210237 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA CHEST	AI-CVD
Tool Name	CINA CHEST	AI-CVD
Company	Avicenna.AI	HeartLung Corporation
Primary Function	AI-powered radiological triage and notification for Pulmonary Embolism (PE) and Aortic Dissection (AD)	AI-powered quantitative imaging platform for opportunistic screening of cardiovascular and multisystem diseases
Key Detections/Measurements	Pulmonary Embolism (PE), Aortic Dissection (AD)	Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry, Epicardial fat volumetry, Aorta and pulmonary artery sizing

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and AI-CVD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and differences in focus between CINA CHEST and AI-CVD?

CINA CHEST is designed for rapid radiological triage and notification of life-threatening conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. In contrast, AI-CVD performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks such as coronary heart disease, heart failure, and osteoporosis.

What types of CT scans are utilized by each tool?

CINA CHEST specifically uses CT angiography scans for the detection and triage of Pulmonary Embolism and Aortic Dissection. AI-CVD leverages existing chest and abdominal CT scans for its opportunistic screening capabilities, without requiring additional imaging.

What specific conditions or measurements do CINA CHEST and AI-CVD identify or quantify?

CINA CHEST focuses on the detection and notification of suspected Pulmonary Embolism and Aortic Dissection. AI-CVD provides automated measurements for opportunistic screening, including Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, aorta and pulmonary artery sizing, lung attenuation, liver attenuation, bone mineral density, and muscle-fat composition.

How do these tools integrate into existing clinical workflows and what is their impact?

CINA CHEST assists hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings for PE and AD. AI-CVD performs opportunistic screening from existing CT scans, claiming no additional imaging, radiation, contrast, or workflow disruption.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform